Companies:

 

Articles:

 

Stock summary

Companies:

 

Immutep Limited (ASX: IMM)

 
Service provided by WebLinkIR

Company news

Cover Image for Immutep doses first patient in Phase II/III efti trial to treat metastatic breast cancer

Immutep doses first patient in Phase II/III efti trial to treat metastatic breast cancer

Cover Image for Immutep’s Chinese partner launches phase II clinical trial for patients with metastatic breast cancer

Immutep’s Chinese partner launches phase II clinical trial for patients with metastatic breast cancer

Cover Image for Immutep announces improved results in two parallel clinical trials into lead drug eftilagimod alpha

Immutep announces improved results in two parallel clinical trials into lead drug eftilagimod alpha

Cover Image for Immutep receives US patent for the use of LAG525 antibody in treating various cancers

Immutep receives US patent for the use of LAG525 antibody in treating various cancers